Market Research Logo

Cancer Biomarkers Market by Type (Protein Biomarker, Genetic Biomarker), Cancer Type (Breast, Melanoma, Leukemia, Lung), Profiling Technology (Omics, Imaging, Immunoassay, Bioinformatics), Application (Diagnosis, Prognostics, R&D) - Global Forecast to 202

Cancer Biomarkers Market by Type (Protein Biomarker, Genetic Biomarker), Cancer Type (Breast, Melanoma, Leukemia, Lung), Profiling Technology (Omics, Imaging, Immunoassay, Bioinformatics), Application (Diagnosis, Prognostics, R&D) - Global Forecast to 2022

“Global cancer biomarkers market projected to grow at CAGR of 12.2%”
The global cancer biomarkers market is projected to reach USD 20.48 billion by 2022 from USD 11.53 billion in 2017, at a CAGR of 12.2% from 2017 to 2022.
Over the years, the cancer biomarkers market has evolved significantly owing to the rising prevalence of cancer, advancements in omics technologies, increasing healthcare expenditure, growth in R&D funding from government and private bodies, and rising demand for personalized medicine in cancer therapies. However, an unfavorable regulatory and reimbursement scenario and the high capital investments required for biomarker development and validation are some factors expected to restrain the market.

“The lung cancer segment is expected to register the highest CAGR’
The cancer biomarkers market on the basis of cancer type is classified into breast, lung, colorectal, prostate, melanoma, leukemia, thyroid, bladder, non-hodgkin’s lymphoma, kidney, and other cancers. The lung cancer segment is expected to register the highest CAGR during the forecast period. The increasing company focus on research on lung cancer biomarkers is the key driver for this market. Increased understanding of the morphology of lung carcinogenesis, development of the high-throughput techniques for biomarker discovery, and increased focus on early detection of cancer are propelling the growth of this market.

“North America is expected to dominate the cancer biomarkers market and APAC growing at the highest CAGR”
North America (comprising the US and Canada) is expected to account for the largest share of the global cancer biomarkers market in 2017. The large share of this geographic segment is mainly attributed to the increasing government support for discovery and development of biomarkers, increasing demand for personalized medicine, adoption of advanced omics technologies for biomarker discovery, and rising use of biomarkers in drug discovery and development by pharmaceutical companies in that region. While the APAC region is expected to register the highest CAGR during the forecast period. The APAC cancer biomarkers market, particularly in China, Japan, and India is expected to witness high growth during the forecast period.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–40%, Tier 2–30%, and Tier 3–30%
• By Designation – Director level–18%, C-Level–27%, and Others–55%
• By Region – North America–50%, Europe–20%, Asia-Pacific–20%, and RoW–10%

Major players in this market that are profiled in the report includes Abbott (US), Affymetrix (US), Roche (Switzerland), Illumina (US), QIAGEN (Netherlands), Agilent (US), Thermo Fisher (US), Merck (US), Becton Dickinson (US), Hologic (US), Danaher (US), and Shimadzu (Japan).

Research Coverage:
From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and challenges). The report also offers market sizes and data on the growth of various segments of the industry. It focuses on emerging and high-growth segments, and high-growth regions. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the cancer biomarkers market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output to remain successful.

Reasons to buy this report:
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on products offered by the top players in the cancer biomarkers market
• Product/Service Enhancement/Innovation: Detailed insights on the upcoming technologies, research & development activities, and new product launches in the cancer biomarkers market
• Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for profiling technologies across various regions
• Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the cancer biomarkers market
• Competitive Assessment: In-depth assessment of market ranking, strategies, products, and manufacturing capabilities of the leading players in the cancer biomarkers market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
      • SECONDARY SOURCES
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • CANCER BIOMARKERS: MARKET SNAPSHOT
    • ASIA PACIFIC CANCER BIOMARKERS MARKET, BY PROFILING TECHNOLOGY AND APPLICATION
    • CANCER BIOMARKERS MARKET SHARE, BY CANCER TYPE, 2017 VS. 2022
    • CANCER BIOMARKERS MARKET SHARE, BY BIOMARKER TYPE, 2015 TO 2022
    • CANCER BIOMARKERS MARKET, BY REGION
  • MARKET OVERVIEW
    • INTRODUCTION
      • DRIVERS
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
  • CANCER BIOMARKERS MARKET, BY BIOMARKER TYPE
    • INTRODUCTION
      • Table CANCER BIOMARKERS MARKET, BY BIOMARKER TYPE, 2015–2022 (USD MILLION)
    • PROTEIN BIOMARKERS
      • Table GLOBAL PROTEIN CANCER BIOMARKERS MARKET, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: PROTEIN CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: PROTEIN CANCER BIOMARKERS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: PROTEIN CANCER BIOMARKERS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
    • GENETIC BIOMARKERS
      • Table GLOBAL GENETIC CANCER BIOMARKERS MARKET, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: GENETIC CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: GENETIC CANCER BIOMARKERS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: GENETIC CANCER BIOMARKERS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
      • LUNG CANCER
      • COLORECTAL CANCER
      • BREAST CANCER
      • PROSTATE CANCER
      • LEUKEMIA
    • OTHER CANCER BIOMARKERS
      • Table GLOBAL OTHER CANCER BIOMARKERS MARKET, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: OTHER CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: OTHER CANCER BIOMARKERS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: OTHER CANCER BIOMARKERS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
  • CANCER BIOMARKER MARKET, BY CANCER TYPE
    • INTRODUCTION
      • Table GLOBAL CANCER BIOMARKERS MARKET, BY CANCER TYPE, 2015–2022 (USD MILLION)
    • BREAST CANCER
      • Table GLOBAL BREAST CANCER BIOMARKERS MARKET, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: BREAST CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: BREAST CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: BREAST CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
    • LUNG CANCER
      • Table GLOBAL LUNG CANCER BIOMARKERS MARKET, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: LUNG CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: LUNG CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: LUNG CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
    • COLORECTAL CANCER
      • Table GLOBAL COLORECTAL CANCER BIOMARKERS MARKET, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: COLORECTAL CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: COLORECTAL CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: COLORECTAL CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
    • PROSTATE CANCER
      • Table GLOBAL PROSTATE CANCER BIOMARKERS MARKET, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: PROSTATE CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: PROSTATE CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: PROSTATE CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
    • NON-HODGKIN'S LYMPHOMA
      • Table GLOBAL NON-HODGKIN'S LYMPHOMA BIOMARKERS MARKET, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: NON-HODGKIN'S LYMPHOMA BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: NON-HODGKIN'S LYMPHOMA BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: NON-HODGKIN'S LYMPHOMA BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
    • MELANOMA
      • Table GLOBAL MELANOMA BIOMARKERS MARKET, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: MELANOMA BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: MELANOMA BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: MELANOMA BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
    • LEUKEMIA
      • Table GLOBAL LEUKEMIA BIOMARKERS MARKET, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: LEUKEMIA BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: LEUKEMIA BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: LEUKEMIA BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
    • THYROID CANCER
      • Table GLOBAL THYROID CANCER BIOMARKERS MARKET, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: THYROID CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: THYROID CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: THYROID CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
    • BLADDER CANCER
      • Table GLOBAL BLADDER CANCER BIOMARKERS MARKET, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: BLADDER CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: BLADDER CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: BLADDER CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
    • KIDNEY CANCER
      • Table GLOBAL KIDNEY CANCER BIOMARKERS MARKET, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: KIDNEY CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: KIDNEY CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: KIDNEY CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
    • OTHER CANCER TYPES
      • Table GLOBAL OTHER CANCER BIOMARKERS MARKET, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: OTHER CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: OTHER CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: OTHER CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
  • CANCER BIOMARKERS MARKET, BY PROFILING TECHNOLOGY
    • INTRODUCTION
      • Table CANCER BIOMARKERS MARKET, BY PROFILING TECHNOLOGY, 2015–2022 (USD MILLION)
      • OMICS TECHNOLOGIES
        • Table CANCER BIOMARKERS MARKET FOR OMICS TECHNOLOGIES, BY TYPE, 2015–2022 (USD MILLION)
        • Table CANCER BIOMARKERS MARKET FOR OMICS TECHNOLOGIES, BY REGION, 2015–2022 (USD MILLION)
        • Table NORTH AMERICA: CANCER BIOMARKERS MARKET FOR OMICS TECHNOLOGIES, BY COUNTRY, 2015–2022 (USD MILLION)
        • Table EUROPE: CANCER BIOMARKERS MARKET FOR OMICS TECHNOLOGIES, BY COUNTRY, 2015–2022 (USD MILLION)
        • Table ASIA PACIFIC: CANCER BIOMARKERS MARKET FOR OMICS TECHNOLOGIES, BY COUNTRY, 2015–2022 (USD MILLION)
      • PROTEOMICS
        • Table CANCER BIOMARKERS MARKET FOR PROTEOMICS, BY REGION, 2015–2022 (USD MILLION)
        • Table NORTH AMERICA: CANCER BIOMARKERS MARKET FOR PROTEOMICS, BY COUNTRY, 2015–2022 (USD MILLION)
        • Table EUROPE: CANCER BIOMARKERS MARKET FOR PROTEOMICS, BY COUNTRY, 2015–2022 (USD MILLION)
        • Table ASIA PACIFIC: CANCER BIOMARKERS MARKET FOR PROTEOMICS, BY COUNTRY, 2015–2022 (USD MILLION)
      • GENOMICS
        • Table CANCER BIOMARKERS MARKET FOR GENOMICS, BY TYPE, 2015–2022 (USD MILLION)
        • Table CANCER BIOMARKERS MARKET FOR GENOMICS, BY REGION, 2015–2022 (USD MILLION)
        • Table NORTH AMERICA: CANCER BIOMARKERS MARKET FOR GENOMICS, BY COUNTRY, 2015–2022 (USD MILLION)
        • Table EUROPE: CANCER BIOMARKERS MARKET FOR GENOMICS, BY COUNTRY, 2015–2022 (USD MILLION)
        • Table ASIA PACIFIC: CANCER BIOMARKERS MARKET FOR GENOMICS, BY COUNTRY, 2015–2022 (USD MILLION)
        • Table CANCER BIOMARKERS MARKET FOR NGS, BY REGION, 2015–2022 (USD MILLION)
        • Table NORTH AMERICA: CANCER BIOMARKERS MARKET FOR NGS, BY COUNTRY, 2015–2022 (USD MILLION)
        • Table EUROPE: CANCER BIOMARKERS MARKET FOR NGS, BY COUNTRY, 2015–2022 (USD MILLION)
        • Table ASIA PACIFIC: CANCER BIOMARKERS MARKET FOR NGS, BY COUNTRY, 2015–2022 (USD MILLION)
        • Table CANCER BIOMARKERS MARKET FOR PCR, BY REGION, 2015–2022 (USD MILLION)
        • Table NORTH AMERICA: CANCER BIOMARKERS MARKET FOR PCR, BY COUNTRY, 2015–2022 (USD MILLION)
        • Table EUROPE: CANCER BIOMARKERS MARKET FOR PCR, BY COUNTRY, 2015–2022 (USD MILLION)
        • Table ASIA PACIFIC: CANCER BIOMARKERS MARKET FOR PCR, BY COUNTRY, 2015–2022 (USD MILLION)
      • OTHER OMICS TECHNOLOGIES
        • Table CANCER BIOMARKERS MARKET FOR OTHER OMICS TECHNOLOGIES, BY REGION, 2015–2022 (USD MILLION)
        • Table NORTH AMERICA: CANCER BIOMARKERS MARKET FOR OTHER OMICS TECHNOLOGIES, BY COUNTRY, 2015–2022 (USD MILLION)
        • Table EUROPE: CANCER BIOMARKERS MARKET FOR OTHER OMICS TECHNOLOGIES, BY COUNTRY, 2015–2022 (USD MILLION)
        • Table ASIA PACIFIC: CANCER BIOMARKERS MARKET FOR OTHER OMICS TECHNOLOGIES, BY COUNTRY, 2015–2022 (USD MILLION)
    • IMAGING TECHNOLOGIES
      • Table CANCER BIOMARKERS MARKET FOR IMAGING TECHNOLOGIES, BY TYPE, 2015–2022 (USD MILLION)
      • Table CANCER BIOMARKERS MARKET FOR IMAGING TECHNOLOGIES, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: CANCER BIOMARKERS MARKET FOR IMAGING TECHNOLOGIES, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: CANCER BIOMARKERS MARKET FOR IMAGING TECHNOLOGIES, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: CANCER BIOMARKERS MARKET FOR IMAGING TECHNOLOGIES, BY COUNTRY, 2015–2022 (USD MILLION)
      • ULTRASOUND
        • Table CANCER BIOMARKERS MARKET FOR ULTRASOUND, BY REGION, 2015–2022 (USD MILLION)
        • Table NORTH AMERICA: CANCER BIOMARKERS MARKET FOR ULTRASOUND, BY COUNTRY, 2015–2022 (USD MILLION)
        • Table EUROPE: CANCER BIOMARKERS MARKET FOR ULTRASOUND, BY COUNTRY, 2015–2022 (USD MILLION)
        • Table ASIA PACIFIC: CANCER BIOMARKERS MARKET FOR ULTRASOUND, BY COUNTRY, 2015–2022 (USD MILLION)
      • COMPUTED TOMOGRAPHY (CT)
        • Table CANCER BIOMARKERS MARKET FOR CT, BY REGION, 2015–2022 (USD MILLION)
        • Table NORTH AMERICA: CANCER BIOMARKERS MARKET FOR CT, BY COUNTRY, 2015–2022 (USD MILLION)
        • Table EUROPE: CANCER BIOMARKERS MARKET FOR CT, BY COUNTRY, 2015–2022 (USD MILLION)
        • Table ASIA PACIFIC: CANCER BIOMARKERS MARKET FOR CT, BY COUNTRY, 2015–2022 (USD MILLION)
      • MAGNETIC RESONANCE IMAGING (MRI)
        • Table CANCER BIOMARKERS MARKET FOR MRI, BY REGION, 2015–2022 (USD MILLION)
        • Table NORTH AMERICA: CANCER BIOMARKERS MARKET FOR MRI, BY COUNTRY, 2015–2022 (USD MILLION)
        • Table EUROPE: CANCER BIOMARKERS MARKET FOR MRI, BY COUNTRY, 2015–2022 (USD MILLION)
        • Table ASIA PACIFIC: CANCER BIOMARKERS MARKET FOR MRI, BY COUNTRY, 2015–2022 (USD MILLION)
      • POSITRON EMISSION TOMOGRAPHY (PET)
        • Table CANCER BIOMARKERS MARKET FOR PET, BY REGION, 2015–2022 (USD MILLION)
        • Table NORTH AMERICA: CANCER BIOMARKERS MARKET FOR PET, BY COUNTRY, 2015–2022 (USD MILLION)
        • Table EUROPE: CANCER BIOMARKERS MARKET FOR PET, BY COUNTRY, 2015–2022 (USD MILLION)
        • Table ASIA PACIFIC: CANCER BIOMARKERS MARKET FOR PET, BY COUNTRY, 2015–2022 (USD MILLION)
      • MAMMOGRAPHY
        • Table CANCER BIOMARKERS MARKET FOR MAMMOGRAPHY, BY REGION, 2015–2022 (USD MILLION)
        • Table NORTH AMERICA: CANCER BIOMARKERS MARKET FOR MAMMOGRAPHY, BY COUNTRY, 2015–2022 (USD MILLION)
        • Table EUROPE: CANCER BIOMARKERS MARKET FOR MAMMOGRAPHY, BY COUNTRY, 2015–2022 (USD MILLION)
        • Table ASIA PACIFIC: CANCER BIOMARKERS MARKET FOR MAMMOGRAPHY, BY COUNTRY, 2015–2022 (USD MILLION)
    • IMMUNOASSAYS
      • Table CANCER BIOMARKERS MARKET FOR IMMUNOASSAYS, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: CANCER BIOMARKERS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: CANCER BIOMARKERS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: CANCER BIOMARKERS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2015–2022 (USD MILLION)
    • CYTOGENETICS
      • Table CANCER BIOMARKERS MARKET FOR CYTOGENETICS, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: CANCER BIOMARKERS MARKET FOR CYTOGENETICS, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: CANCER BIOMARKERS MARKET FOR CYTOGENETICS, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: CANCER BIOMARKERS MARKET FOR CYTOGENETICS, BY COUNTRY, 2015–2022 (USD MILLION)
      • IN SITU HYBRIDIZATION (ISH)
        • Table CANCER BIOMARKERS MARKET FOR ISH, BY REGION, 2015–2022 (USD MILLION)
        • Table NORTH AMERICA: CANCER BIOMARKERS MARKET FOR ISH, BY COUNTRY, 2015–2022 (USD MILLION)
        • Table EUROPE: CANCER BIOMARKERS MARKET FOR ISH, BY COUNTRY, 2015–2022 (USD MILLION)
        • Table ASIA PACIFIC: CANCER BIOMARKERS MARKET FOR ISH, BY COUNTRY, 2015–2022 (USD MILLION)
      • OTHER CYTOGENETICS-BASED TESTS
        • Table CANCER BIOMARKERS MARKET FOR OTHER CYTOGENETICS-BASED TESTS, BY REGION, 2015–2022 (USD MILLION)
        • Table NORTH AMERICA: CANCER BIOMARKERS MARKET FOR OTHER CYTOGENETICS-BASED TESTS, BY COUNTRY, 2015–2022 (USD MILLION)
        • Table EUROPE: CANCER BIOMARKERS MARKET FOR OTHER CYTOGENETICS-BASED TESTS, BY COUNTRY, 2015–2022 (USD MILLION)
        • Table ASIA PACIFIC: CANCER BIOMARKERS MARKET FOR OTHER CYTOGENETICS-BASED TESTS, BY COUNTRY, 2015–2022 (USD MILLION)
    • BIOINFORMATICS
      • Table GLOBAL CANCER BIOMARKERS MARKET FOR BIOINFORMATICS, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: CANCER BIOMARKERS MARKET FOR BIOINFORMATICS, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: CANCER BIOMARKERS MARKET FOR BIOINFORMATICS, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: CANCER BIOMARKERS MARKET FOR BIOINFORMATICS, BY COUNTRY, 2015–2022 (USD MILLION)
  • CANCER BIOMARKERS MARKET, BY APPLICATION
    • INTRODUCTION
      • Table GLOBAL CANCER BIOMARKERS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
    • DIAGNOSTICS
      • Table GLOBAL CANCER BIOMARKERS MARKET FOR DIAGNOSTICS, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: CANCER BIOMARKERS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: CANCER BIOMARKERS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: CANCER BIOMARKERS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2015–2022 (USD MILLION)
    • RESEARCH AND DEVELOPMENT
      • Table GLOBAL CANCER BIOMARKERS MARKET FOR RESEARCH AND DEVELOPMENT, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: CANCER BIOMARKERS MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: CANCER BIOMARKERS MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: CANCER BIOMARKERS MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY, 2015–2022 (USD MILLION)
    • PROGNOSTICS
      • Table GLOBAL CANCER BIOMARKERS MARKET FOR PROGNOSTICS, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: CANCER BIOMARKERS MARKET FOR PROGNOSTICS, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: CANCER BIOMARKERS MARKET FOR PROGNOSTICS, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: CANCER BIOMARKERS MARKET FOR PROGNOSTICS, BY COUNTRY, 2015–2022 (USD MILLION)
    • RISK ASSESSMENT
      • Table GLOBAL CANCER BIOMARKERS MARKET FOR RISK ASSESSMENT, BY REGION, 2015– 2022 (USD MILLION)
      • Table NORTH AMERICA: CANCER BIOMARKERS MARKET FOR RISK ASSESSMENT, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: CANCER BIOMARKERS MARKET FOR RISK ASSESSMENT, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: CANCER BIOMARKERS MARKET FOR RISK ASSESSMENT, BY COUNTRY, 2015–2022 (USD MILLION)
    • OTHER APPLICATIONS
      • Table GLOBAL CANCER BIOMARKERS MARKET FOR OTHER APPLICATIONS, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: CANCER BIOMARKERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: CANCER BIOMARKERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: CANCER BIOMARKERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION)
  • CANCER BIOMARKERS MARKET, BY REGION
    • INTRODUCTION
      • Table GLOBAL CANCER BIOMARKERS MARKET, BY REGION, 2015–2022 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: CANCER BIOMARKERS MARKET, BY CANCER TYPE, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: CANCER BIOMARKERS MARKET, BY BIOMARKER TYPE, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: CANCER BIOMARKERS MARKET, BY PROFILING TECHNOLOGY, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: OMICS TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: GENOMICS TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: IMAGING TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: CYTOGENETICS MARKET, BY TYPE, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: CANCER BIOMARKERS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
      • US
        • Table US: CANCER BIOMARKERS MARKET, BY CANCER TYPE, 2015–2022 (USD MILLION)
        • Table US: CANCER BIOMARKERS MARKET, BY BIOMARKER TYPE, 2015–2022 (USD MILLION)
        • Table US: CANCER BIOMARKERS MARKET, BY PROFILING TECHNOLOGY, 2015–2022 (USD MILLION)
        • Table US: OMICS TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table US: GENOMICS TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table US: IMAGING TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table US: CYTOGENETICS MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table US: CANCER BIOMARKERS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
      • CANADA
        • Table CANADA: CANCER BIOMARKERS MARKET, BY CANCER TYPE, 2015–2022 (USD MILLION)
        • Table CANADA: CANCER BIOMARKERS MARKET, BY BIOMARKER TYPE, 2015–2022 (USD MILLION)
        • Table CANADA: CANCER BIOMARKERS MARKET, BY PROFILING TECHNOLOGY, 2015–2022 (USD MILLION)
        • Table CANADA: OMICS TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table CANADA: GENOMICS TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table CANADA: IMAGING TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table CANADA: CYTOGENETICS MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table CANADA: CANCER BIOMARKERS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
    • EUROPE
      • Table EUROPE :CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: CANCER BIOMARKERS MARKET, BY CANCER TYPE, 2015–2022 (USD MILLION)
      • Table EUROPE: CANCER BIOMARKERS MARKET, BY BIOMARKER TYPE, 2015–2022 (USD MILLION)
      • Table EUROPE: CANCER BIOMARKERS MARKET, BY PROFILING TECHNOLOGY, 2015–2022 (USD MILLION)
      • Table EUROPE: OMICS TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
      • Table EUROPE: GENOMICS TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
      • Table EUROPE: IMAGING TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
      • Table EUROPE: CYTOGENETICS MARKET, BY TYPE, 2015–2022 (USD MILLION)
      • Table EUROPE: CANCER BIOMARKERS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
      • GERMANY
        • Table GERMANY: CANCER BIOMARKERS MARKET, BY CANCER TYPE, 2015–2022 (USD MILLION)
        • Table GERMANY: CANCER BIOMARKERS MARKET, BY BIOMARKER TYPE, 2015–2022 (USD MILLION)
        • Table GERMANY: CANCER BIOMARKERS MARKET, BY PROFILING TECHNOLOGY, 2015–2022 (USD MILLION)
        • Table GERMANY: OMICS TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table GERMANY: GENOMICS TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table GERMANY: IMAGING TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table GERMANY: CYTOGENETICS MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table GERMANY: CANCER BIOMARKERS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
      • UK
        • Table UK: CANCER BIOMARKERS MARKET, BY CANCER TYPE, 2015–2022 (USD MILLION)
        • Table UK: CANCER BIOMARKERS MARKET, BY BIOMARKER TYPE, 2015–2022 (USD MILLION)
        • Table UK: CANCER BIOMARKERS MARKET, BY PROFILING TECHNOLOGY, 2015–2022 (USD MILLION)
        • Table UK: OMICS TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table UK: GENOMICS TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table UK: IMAGING TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table UK: CYTOGENETICS MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table UK: CANCER BIOMARKERS MARKET, BY APPLICATION , 2015–2022 (USD MILLION)
      • FRANCE
        • Table FRANCE: CANCER BIOMARKERS MARKET, BY CANCER TYPE, 2015–2022 (USD MILLION)
        • Table FRANCE: CANCER BIOMARKERS MARKET, BY BIOMARKER TYPE, 2015–2022 (USD MILLION)
        • Table FRANCE: CANCER BIOMARKERS MARKET, BY PROFILING TECHNOLOGY, 2015–2022 (USD MILLION)
        • Table FRANCE: OMICS TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table FRANCE: GENOMICS TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table FRANCE: IMAGING TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table FRANCE: CYTOGENETICS MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table FRANCE: CANCER BIOMARKERS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
      • ITALY
        • Table ITALY: CANCER BIOMARKERS MARKET, BY CANCER TYPE, 2015–2022 (USD MILLION)
        • Table ITALY: CANCER BIOMARKERS MARKET, BY BIOMARKER TYPE, 2015–2022 (USD MILLION)
        • Table ITALY: CANCER BIOMARKERS MARKET, BY PROFILING TECHNOLOGY, 2015–2022 (USD MILLION)
        • Table ITALY: OMICS TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table ITALY: GENOMICS TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table ITALY: IMAGING TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table ITALY: CYTOGENETICS MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table ITALY: CANCER BIOMARKERS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
      • SPAIN
        • Table SPAIN: CANCER BIOMARKERS MARKET, BY CANCER TYPE, 2015–2022 (USD MILLION)
        • Table SPAIN: CANCER BIOMARKERS MARKET, BY BIOMARKER TYPE, 2015–2022 (USD MILLION)
        • Table SPAIN: CANCER BIOMARKERS MARKET, BY PROFILING TECHNOLOGY, 2015–2022 (USD MILLION)
        • Table SPAIN: OMICS TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table SPAIN: GENOMICS TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table SPAIN: IMAGING TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table SPAIN: CYTOGENETICS MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table SPAIN: CANCER BIOMARKERS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
      • REST OF EUROPE (ROE)
        • Table ROE: CANCER BIOMARKERS MARKET, BY CANCER TYPE, 2015–2022 (USD MILLION)
        • Table ROE: CANCER BIOMARKERS MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table ROE: CANCER BIOMARKERS MARKET, BY PROFILING TECHNOLOGY, 2015–2022 (USD MILLION)
        • Table ROE: OMICS TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table ROE: GENOMICS TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table ROE: IMAGING TECHNOLOGIES MARKET, 2015–2022 (USD MILLION)
        • Table ROE: CYTOGENETICS MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table ROE: CANCER BIOMARKERS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
    • ASIA PACIFIC
      • Table ASIA PACIFIC: CANCER BIOMARKERS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: CANCER BIOMARKERS MARKET, BY CANCER TYPE, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: CANCER BIOMARKERS MARKET, BY TYPE, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: CANCER BIOMARKERS MARKET, BY PROFILING TECHNOLOGY, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: OMICS TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: GENOMICS TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: IMAGING TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: CYTOGENETICS MARKET, BY TYPE, 2015–2022 (USD MILLION)
      • Table ASIA PACIFIC: CANCER BIOMARKERS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
      • JAPAN
        • Table JAPAN: CANCER BIOMARKERS MARKET, BY CANCER TYPE, 2015–2022 (USD MILLION)
        • Table JAPAN: CANCER BIOMARKERS MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table JAPAN: CANCER BIOMARKERS MARKET, BY PROFILING TECHNOLOGY, 2015–2022 (USD MILLION)
        • Table JAPAN: OMICS TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table JAPAN: GENOMICS TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table JAPAN: IMAGING TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table JAPAN: CYTOGENETICS MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table JAPAN: CANCER BIOMARKERS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
      • REST OF APAC
        • Table REST OF APAC: CANCER BIOMARKERS MARKET, BY CANCER TYPE, 2015–2022 (USD MILLION)
        • Table REST OF APAC: CANCER BIOMARKERS MARKET, BY BIOMARKER TYPE, 2015–2020 (USD MILLION)
        • Table REST OF APAC: CANCER BIOMARKERS MARKET, BY PROFILING TECHNOLOGY, 2015–2022 (USD MILLION)
        • Table REST OF APAC: OMICS TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table REST OF APAC: GENOMICS TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table REST OF APAC: IMAGING TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table REST OF APAC: CYTOGENETICS MARKET, BY TYPE, 2015–2022 (USD MILLION)
        • Table REST OF APAC: CANCER BIOMARKERS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
    • REST OF THE WORLD (ROW)
      • Table ROW: CANCER BIOMARKERS MARKET, BY CANCER TYPE, 2015–2022 (USD MILLION)
      • Table ROW: CANCER BIOMARKERS MARKET, BY TYPE, 2015–2022 (USD MILLION)
      • Table ROW: CANCER BIOMARKERS MARKET, BY PROFILING TECHNOLOGY, 2015–2022 (USD MILLION)
      • Table ROW: OMICS TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
      • Table ROW: GENOMICS TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
      • Table ROW: IMAGING TECHNOLOGIES MARKET, BY TYPE, 2015–2022 (USD MILLION)
      • Table ROW: CYTOGENETICS MARKET, BY TYPE, 2015–2022 (USD MILLION)
      • Table ROW: CANCER BIOMARKERS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • MARKET RANKING ANALYSIS, 2016
      • Table RANK OF COMPANIES IN THE GLOBAL CANCER BIOMARKERS MARKET, 2016
  • COMPANY PROFILES
    • THERMO FISHER SCIENTIFIC
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • BIO-RAD LABORATORIES
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • ROCHE DIAGNOSTICS
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • QIAGEN N.V.
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • ILLUMINA
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • GE HEALTHCARE
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • AGILENT TECHNOLOGIES
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • BIOMÉRIEUX SA
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • MERCK & CO.
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • ABBOTT LABORATORIES
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • BECTON, DICKINSON AND COMPANY
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • DANAHER CORPORATION
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • MYRIAD GENETICS
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • SYSMEX CORPORATION
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • HOLOGIC
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • QUEST DIAGNOSTICS
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
  • APPENDIX
    • INSIGHTS OF INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report